Regis Corporation (RGS)
USD 21.95
(-4.57%)
USD 21.95
(-4.57%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.04 Million | -7.88 Million | -38.63 Million | -99.88 Million | -86.4 Million | -17.52 Million |
| Net Income | 91.06 Million | -7.38 Million | -85.85 Million | -113.33 Million | -171.36 Million | -14.22 Million |
| Depreciation & Amortization | 3.4 Million | 7.18 Million | 6.5 Million | 17.87 Million | 33.1 Million | 33.26 Million |
| Deferred income taxes | 519 Thousand | -8000.00 | 391 Thousand | -3.38 Million | -3.93 Million | -9.81 Million |
| Stock-based compensation | 1.55 Million | 2.31 Million | 1.33 Million | 3.25 Million | 3.27 Million | 9 Million |
| Change in working capital | -9.6 Million | -13.6 Million | -29.05 Million | -32.56 Million | -37.61 Million | -58.1 Million |
| Other non-cash items | 6.83 Million | 3.6 Million | 68.04 Million | 28.27 Million | 90.12 Million | 22.35 Million |
| Investing Cash Flow | 1.62 Million | 4.01 Million | 7.68 Million | -2.09 Million | 61.02 Million | 87.78 Million |
| Investments in PPE | -376 Thousand | -481 Thousand | -5.31 Million | -11.47 Million | -37.49 Million | -31.61 Million |
| Acquisitions | 2 Million | 4.5 Million | 13 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 2 Million | 4.5 Million | 13 Million | 9.37 Million | 98.52 Million | 119.4 Million |
| Financing Cash Flow | 8.36 Million | -2.14 Million | 29.42 Million | 7.77 Million | 56.16 Million | -126.69 Million |
| Debt repayment | -22.73 Million | -11.08 Million | -16.91 Million | -1.31 Million | -126.26 Million | -378 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -36 Thousand | -845 Thousand | -348 Thousand | -28.24 Million | -152.66 Million |
| Common Stock Issuance | - | - | 37.18 Million | - | - | - |
| Other Financing Activities | -14.37 Million | 8.97 Million | 10.84 Million | 9.43 Million | 210.68 Million | 26.34 Million |
| Accounts receivables | 848 Thousand | 943 Thousand | 11.89 Million | -279 Thousand | -3.9 Million | -17.3 Million |
| Accounts payables | -1.6 Million | -497 Thousand | -10.96 Million | -21.66 Million | 4.58 Million | -5.83 Million |
| Inventory | - | -182 Thousand | 7.88 Million | 17.87 Million | -2.25 Million | -8.49 Million |
| Other working capital | -10.07 Million | -13.86 Million | -37.87 Million | -28.49 Million | -36.04 Million | -26.47 Million |
| Cash at beginning of period | 21.39 Million | 27.46 Million | 29.15 Million | 122.88 Million | 92.37 Million | 148.77 Million |
| Cash at end of period | 29.31 Million | 21.39 Million | 27.46 Million | 29.15 Million | 122.88 Million | 92.37 Million |
| Capital Expenditure | -376 Thousand | -481 Thousand | -5.31 Million | -11.47 Million | -37.49 Million | -31.61 Million |
| Effect of forex changes on cash | -31 Thousand | -53 Thousand | -158 Thousand | 477 Thousand | -284 Thousand | 35 Thousand |
| Net cash flow / Change in cash | 7.91 Million | -6.06 Million | -1.68 Million | -93.72 Million | 30.5 Million | -56.39 Million |
| Free Cash Flow | -2.41 Million | -8.37 Million | -43.95 Million | -111.35 Million | -123.9 Million | -49.14 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 91.06 Million | 91.2 Million | -2.33 Million | 997 Thousand | 1.19 Million | -7.38 Million |
| Depreciation & Amortization | 3.4 Million | 1.82 Million | 571 Thousand | 630 Thousand | 375 Thousand | 7.18 Million |
| Deferred income taxes | 519 Thousand | 569 Thousand | -21 Thousand | 30 Thousand | -59 Thousand | -8000.00 |
| Stock-based compensation | 1.55 Million | 357 Thousand | 311 Thousand | 260 Thousand | 630 Thousand | 2.31 Million |
| Change in working capital | -9.6 Million | 2.69 Million | -464 Thousand | -5.24 Million | -6.58 Million | -13.6 Million |
| Other non-cash items | 6.83 Million | 2.42 Million | 1.65 Million | -701 Thousand | 1.62 Million | 3.6 Million |
| Investing Cash Flow | 1.62 Million | -4000.00 | 1.95 Million | -160 Thousand | -163 Thousand | 4.01 Million |
| Investments in PPE | -376 Thousand | -4000.00 | -49 Thousand | -160 Thousand | -163 Thousand | -481 Thousand |
| Acquisitions | 2 Million | -2 Million | 2 Million | - | - | 4.5 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 2 Million | 2 Million | - | - | - | 4.5 Million |
| Financing Cash Flow | 8.36 Million | 9.43 Million | -3.38 Million | 636 Thousand | 1.68 Million | -2.14 Million |
| Debt repayment | -22.73 Million | -21.23 Million | -2.04 Million | -293 Thousand | -162 Thousand | -11.08 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -36 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -14.37 Million | -11.8 Million | -1.33 Million | 929 Thousand | 1.84 Million | 8.97 Million |
| Accounts receivables | 848 Thousand | 848 Thousand | - | - | - | 943 Thousand |
| Accounts payables | -1.6 Million | -1.6 Million | - | - | - | -497 Thousand |
| Inventory | - | - | - | - | - | -182 Thousand |
| Other working capital | - | 2.69 Million | - | - | - | -13.86 Million |
| Cash at beginning of period | 21.39 Million | 14.81 Million | 16.58 Million | 20.04 Million | 21.39 Million | 27.46 Million |
| Cash at end of period | 29.31 Million | 29.31 Million | 14.81 Million | 16.58 Million | 20.04 Million | 21.39 Million |
| Capital Expenditure | -376 Thousand | -4000.00 | -49 Thousand | -160 Thousand | -163 Thousand | -481 Thousand |
| Effect of forex changes on cash | -31 Thousand | -20 Thousand | -57 Thousand | 88 Thousand | -42 Thousand | -53 Thousand |
| Net cash flow / Change in cash | 7.91 Million | 14.49 Million | -1.76 Million | -3.46 Million | -1.34 Million | -6.06 Million |
| Free Cash Flow | -2.41 Million | 5.08 Million | -326 Thousand | -4.18 Million | -2.98 Million | -8.37 Million |
SYMPHONY
AWSL
VCLD
RELAXO
002922
TRI